• Indian Indices
  • Global Indices
  • Commodities
  • Currency
Sensex
  • Sensex
  • Nifty
{{x.close_price| number:2}} {{x.netchg| number:2}} ({{x.perchg | number:2}}%)
Open - {{x.open | number:2}}
Prev Close - {{x.prevclose|number:2}}
Today's High - {{x.high|number:2}}
Today's Low - {{x.low|number:2}}
Advances/Declines (30 Companies)
  • 1D
  • 1W
  • 1M
  • 1Yr
  • 5Yr
{{x.upd_time}}
FTSE 100
  • FTSE 100
  • DJIA
  • NIKKEI 225
  • HANG SENG
{{x.Date}}
{{x.close| number:2}} {{x.Chg | number:2}} ({{x.PChg | number:2}}%)
Open - {{x.close | number:2}}
Prev Close - {{x.PrevClose|number:2}}
Gold
  • Gold
  • Silver
  • Crude Oil
  • Copper
{{x.Trd_Date}} ( {{x.Time}} )
{{x.ClosePrice| number:2}} {{x.change| number:2}} ({{x.perchange | number:2}}%)
Exchange - MCX
Open - {{x.Open|number:2}}
Exp Date - {{x.Exp_Date}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevClose|number:2}}
Today's Low - {{x.Low|number:2}}
USDINR
  • USDINR
  • GBPINR
  • EURINR
  • JPYINR
{{x.Lasttrdtime}} ( {{x.Time}} )
{{x.ltp| number:2}} {{x.PriceDiff| number:2}} ({{x.PerChange | number:2}}%)
Exchange - NSE
Open - {{x.Open|number:2}}
Exp Date - {{x.Expirydate}}
Today's High - {{x.High|number:2}}
Prev. Close - {{x.PrevPrice|number:2}}
Today's Low - {{x.Low|number:2}}
As On 28-Jan-2021 16:01 PM
46,874.36
-535.57 (-1.13%)
NIFTY
13,817.55
-149.95 (-1.07%)
SENSEX
    No Companies Visited

Back to news list
  • Gland Pharma IPO subscribed 4%

    The issue received bids for 12.69 lakh shares as against 3.02 crore shares on offer.

    The initial public offer (IPO) of Gland Pharma received bids for 12.69 lakh shares on Monday, 9 November 2020, as against 3.02 crore shares on offer, as per the National Stock Exchange of India (NSE) website data at 17:00 IST. The issue was subscribed 0.04 times.

    The issue opened for bidding today, 9 November 2020 and it will close on Wednesday, 11 November 2020. The price band for the IPO is set at Rs 1490-1500 per share.

    The IPO consists of fresh issue of shares amounting to Rs 1250 crore and an offer of sale of 3,48,63,635 shares by the selling shareholders.

    Ahead of the IPO, the Hyderabad-based generic injectables-focused company allotted 1,29,59,089 shares to 70 anchor investors at Rs 1,500 per share aggregating to Rs 1,943.86 crore.

    Overseas investors included SmallCap World Fund INC, Government of Singapore, The Nomura Trust And Banking Co and Goldman Sachs.

    Out of the total 1,29,59,089 shares allotted to anchor investors, the company allocated 43,19,700 shares (or 33.33% of the total anchor allotment portion) to 18 domestic mutual funds through a total of 77 schemes.

    The proceeds of the offer for sale shall be received by the selling shareholders. The company proposes to utilise the net proceeds of the fresh issue towards funding incremental working capital requirements; funding capital expenditure requirements; and general corporate purposes.

    The company recorded net profit of Rs 313.59 crore and total income of Rs 916.28 crore in the quarter ended on 30 June 2020.

    Hyderabad-based Gland Pharma is one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. It operates primarily under a business to business (B2B) model and it engaged in development, manufacturing and marketing of complex injectables. The company is promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

    Back to news list
Previous Stories :
More

Quick Links

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

The power of the database is harnessed by our fired-up reporters to generate interesting ideas. The reader-friendly presentation of the idea, supplemented by relevant data and information, can be accessed online through Capita Telefolio and Telefolio Gold. These ideas are used by individual investors as well as institutional investors to do further research and stay ahead.

Capital Market Publishers India Pvt. Ltd.

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071.
91-22-25229720
91-22-25230011
Kindly note www.capitalmarket.com does not send any mobile SMS, whatsapp or twitter messages
giving any kind of stock recommendations.
For Capital Market Magazine queries mail to : subscription@capitalmarket.com
For Capital Market Online Products related queries mail to : financeshop@capitalmarket.com
For any other Capital Market Website related Queries mail to : info@capitalmarket.com
To advertise on Capital Market Websites & Capital Market Fortnightly magazine mail to : advt@capitalmarket.com
Flash News 28-Jan-2021
  •  ( 15:17) IDBI Bank Q3 PAT stands at Rs 378 cr  
  •  ( 13:33) The Nifty index trades beneath 13,800; negative market breadth  
  •  ( 13:33) European markets open lower after sharp sell-off on Wall Street  
  •  ( 13:32) Indices at day's low, continues to incur massive losses  
  •  ( 12:41) Media stocks snap 4-day losing streak; positive market breadth  
  •  ( 12:40) UN: India’s economy is projected to grow at 7.3% in 2021  
  •  ( 12:40) The January 2021 F&O contracts will expire today, 28 January 2021  
  •  ( 12:39) Indices at day's low, continues to incur massive losses  
  •  ( 12:05) NTPC commissions 140 MW capacity Bilhaur Solar PV project in UP  
  •  ( 11:37) Hero MotoCorp sets foot in Mexico with Group Salinas  
  •  ( 11:26) Asian markets edge lower  
  •  ( 11:26) Auto stocks witness value buying  
  •  ( 11:25) Indices turn rangebound  
  •  ( 11:16) Axis Bank Q3 PAT down 36.4% Y-o-Y to Rs 1,116.60 cr  
  •  ( 10:41) JK Paper consol. Q3 PAT down 51% Y-o-Y to Rs 64.59 cr  
  •  ( 10:26) Quess Corp consol. Q3 PAT up 39.1% Y-o-Y to Rs 45.58 cr  
  •  ( 10:05) ABFRL to buy 51% stake in Sabyasachi for Rs 398 cr  
  •  ( 09:39) Glenmark Pharma receives USFDA approval for Amphetamine Sulfate tablets  
  •  ( 09:25) Tata Coffee consol. Q3 PAT up 19.5% Y-o-Y to Rs 50.18 cr  
  •  ( 09:23) United Spirits Q3 PAT declines 11% YoY to Rs 230 cr  
  •  ( 09:21) Market drops in early trade  
  •  ( 09:18) Astral Poly board to mull bonus issue of Feb 3  
  •  ( 08:15) US Fed maintains monetary stimulus, cites moderating recovery  
  •  ( 08:11) US stocks slump on Wednesday in wake of Fed statement  
  •  ( 08:09) Asia-Pacific stocks decline  
Show News
28 January 2021 16:01
2445.05
(0.37 %)
670.85
(6.16 %)
4132.00
(-0.46 %)
4812.90
(-0.66 %)
8936.90
(-2.08 %)
571.00
(0.04 %)
4876.35
(-0.66 %)
2425.00
(-1.69 %)
934.85
(-2.17 %)
1370.20
(-2.81 %)
2303.60
(-3.65 %)
528.15
(1.12 %)
802.60
(-2.18 %)
1276.30
(-1.96 %)
206.50
(-1.99 %)
1722.50
(-2.25 %)
1345.00
(-1.08 %)
765.75
(-0.53 %)
7586.25
(-3.56 %)
17375.40
(-0.98 %)
91.50
(0.22 %)
90.70
(1.17 %)
187.50
(-2.60 %)
1876.60
(-0.98 %)
282.40
(2.47 %)
564.40
(-0.95 %)
3199.45
(-1.89 %)
982.55
(-1.46 %)
1450.30
(0.63 %)
5445.00
(0.72 %)
Sensex 5min and Nifty 15min delayed as on .
Show Ticker
Rotate your device

Rotate your device

For the best experience please go back to portrait mode.